Efficacy and Safety of Naldemedine in Treating Opioid-induced Constipation

PHASE3CompletedINTERVENTIONAL
Enrollment

553

Participants

Timeline

Start Date

November 4, 2013

Primary Completion Date

June 9, 2015

Study Completion Date

June 9, 2015

Conditions
Opioid-induced Constipation
Interventions
DRUG

Naldemedine

Naldemedine 0.2 mg tablet taken orally once a day

DRUG

Placebo

Placebo tablet taken orally once a day

Trial Locations (49)

Unknown

Shionogi Research Site, Birmingham

Shionogi Research Site, Homewood

Shionogi Research Site, Goodyear

Shionogi Research Site, Little Rock

Shionogi Research Site, Anaheim

Shionogi Research Site, Buena Park

Shionogi Research Site, Corona

Shionogi Research Site, Gold River

Shionogi Research Site, Los Angeles

Shionogi Research Site, Modesto

Shionogi Research Site, Pasadena

Shionogi Research Site, Coral Gables

Shionogi Research Site, Hialeah

Shionogi Research Site, Jacksonville

Shionogi Research Site, Miami

Shionogi Research Site, Miami Beach

Shionogi Research Site, Plantation

Shionogi Research Site, Columbus

Shionogi Research Site, Evansville

Shionogi Research Site, Indianapolis

Shionogi Research Site, West Des Moines

Shionogi Research Site, Edgewood

Shionogi Research Site, Crowley

Shionogi Research Site, Kalamazoo

Shionogi Research Site, Traverse City

Shionogi Research Site, Butte

Shionogi Research Site, Omaha

Shionogi Research Site, Las Vegas

Shionogi Research Site, Omaha

Shionogi Research Site, Albuquerque

Shionogi Research Site, Hopewell Junction

Shionogi Research Site, Mooresville

Shionogi Research Site, Winston-Salem

Shionogi Research Site, Dayton

Shionogi Research Site, Marion

Shionogi Research Site, Media

Shionogi Research Site, Spartanburg

Shionogi Research Site, Knoxville

Shionogi Research Site, Tullahoma

Shionogi Research Site, Channelview

Shionogi Research Site, Fort Worth

Shionogi Research Site, Groesbeck

Shionogi Research Site, Houston

Shionogi Research Site, Plano

Shionogi Research Site, San Antonio

Shionogi Research Site, Chesapeake

Shionogi Research Site, Chester

Shionogi Research Site, Tacoma

Shionogi Research Site, Clarksburg

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Shionogi

INDUSTRY

NCT01993940 - Efficacy and Safety of Naldemedine in Treating Opioid-induced Constipation | Biotech Hunter | Biotech Hunter